cholestyramine resin has been researched along with 8-hydroxy-2'-deoxyguanosine in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (8-hydroxy-2'-deoxyguanosine) | Trials (8-hydroxy-2'-deoxyguanosine) | Recent Studies (post-2010) (8-hydroxy-2'-deoxyguanosine) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 4,821 | 238 | 2,164 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abaterusso, C; Abhyankar, A; Brocco, E; Carraro, A; Faedda, R; Luthman, H; Morgia, G; Nosadini, R; Satta, A; Tonolo, G; Velussi, M | 1 |
1 trial(s) available for cholestyramine resin and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albumins; Albuminuria; Anticholesteremic Agents; Cholestyramine Resin; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Lipids; Male; Middle Aged; Podocytes; Proteins; RNA, Messenger; Simvastatin | 2006 |